Smooth Muscle-Specific Expression of CYP4A1 Induces Endothelial Sprouting in Renal Arterial Microvessels

Circulation Research

Volumn 94, Issue 2, 2004, Pages 167-174

  Jiang, Miao ^a   Mezentsev, Alexandre ^a   Kemp, Rowena ^a   Byun, Kihwan ^b   Falck, John R ^b   Miano, Joseph M ^c   Nasjletti, Alberto ^a   Abraham, Nader G ^a   Laniado Schwartzman, Michal ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

20 HETE; Adenovirus; Angiogenesis; Cytochrome P450

Indexed keywords

12 HYDROXYLAURIC ACID; 20 HYDROXYICOSATETRAENOIC ACID; ADENOVIRUS VECTOR; ARACHIDONIC ACID OMEGA HYDROXYLASE; BETA GALACTOSIDASE; BETA GALACTOSIDE; COMPLEMENTARY DNA; CYTOCHROME P450 4A; CYTOCHROME P450 4A1; CYTOCHROME P450 INHIBITOR; FORMAMIDINE; ICOSANOID; LAURIC ACID; MESSENGER RNA; MITOGENIC AGENT; N (4 BUTYL 2 METHYLPHENYL) N' HYDROXYFORMAMIDINE; OXYGENASE; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT;

ANGIOGENESIS; ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; CATALYST; CELL LINE; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME INHIBITION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; KIDNEY ARTERY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REACTION TIME; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

3T3 CELLS; ADENOVIRIDAE; AMIDINES; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; GENETIC VECTORS; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; LAURIC ACIDS; MALE; MICE; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN SPECIFICITY; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; RENAL ARTERY; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1042279546     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000111523.12842.FC     Document Type: Article

References (38)

1. Gibson GG. Comparative aspects of the mammalian cytochrome P450 IV gene family. Xenobiotica. 1989;19:1123-1148.
2. Hardwick JP. CYP4A subfamily: functional analysis by immunohistochemistry and in situ hybridization. Methods Enzymol. 1991;206: 273-283.
3. Nguyen X, Wang MH, Reddy KM, Falck JR, Schwartzman ML. Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors. Am J Physiol. 1999;276:R1691-R1700.
4. Bell DR, Bars RG, Elcombe CR. Differential tissue-specific expression and induction of cytochrome P450IVA1 and acyl-CoA oxidase. Eur J Biochem. 1992;206:979-986.
5. Kimura S, Hardwick JP, Kozak CA, Gonzalez FJ. The rat clofibrate-inducible CYP4A subfamily, II: cDNA sequence of IVA3, mapping of the Cyp4a locus to mouse chromosome 4, and coordinate and tissue-specific regulation of the CYP4A genes. DNA. 1989;8:517-525.
6. Kimura S. Hanioka N. Matsunaga E, Gonzalez FJ. The rat clofibrate-inducible CYP4A gene subfamily. I: complete intron and exon sequence of the CYP4A1 and CYP4A2 genes, unique exon organization, and identification of a conserved 19-bp upstream element. DNA. 1989;8: 503-516.
7. Persohn E, Thomas H, Waechter F. Immunoelectron microscopic localization of cytochrome P-450 isoenzyme CYP4A1 in liver, ileum and kidney of nafenopin treated male rats. Cell Biol Int. 1993;17:99-103.
8. Schwartzman ML, da Silva JL, Lin F, Nishimura M, Abraham NG. Cytochrome P450 4A expression and arachidonic acid Ω-hydroxylation in the kidney of the spontaneously hypertensive rat. Nephron. 1996;73: 652-663.
9. Ito O, Alonso-Galicia M, Hopp KA, Roman RJ. Localization of cytochrome P-450 4A isoforms along the rat nephron. Am J Physiol. 1998; 274:F395-F404.
10. Marji JS, Wang MH, Laniado-Schwartzman M. Cytochrome P-450 4A isoform expression and 20-HETE synthesis in renal preglomerular arteries. Am J Physiol Renal Physiol. 2002;283:F60-F67.
11. Wang MH, Guan H, Nguyen X, Zand BA, Nasjletti A, Laniado-Schwartzman M. Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys. Am J Physiol. 1999;276:F246-F253.
12. Wang MH, Zhang F, Marji J, Zand BA, Nasjletti A, Laniado-Schwartzman M. CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR. Am J Physiol Regul Integr Comp Physiol. 2001;280:R255-R261.
13. Gebremedhin D, Lange AR, Lowry TF, Taheri MR, Birks EK, Hudetz AG, Narayanan J, Falck JR, Okamoto H, Roman RJ, Nithipatikom K, Campbell WB, Harder DR. Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res. 2000;87:60-65.
14. Imig JD, Zou AP, Stec DE, Harder DR, Falck JR, Roman RJ. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol. 1996;270:R217-R227.
15. Harder DR, Lange AR, Gebremedhin D, Birks EK, Roman RJ. Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue. J Vasc Res. 1997;34:237-243.
16. Zhu D, Zhang C, Medhora M, Jacobs ER. CYP4A mRNA, protein, and product in rat lungs: novel localization in vascular endothelium. J Appl Physiol. 2002;93:330-337.
17. + channel in renal arterioles. Am J Physiol. 1996;270: R228-R237.
18. Uddin MR, Muthalif MM, Karzoun NA, Benter IF, Malik KU. Cytochrome P450 metabolites mediate norepinephrine-induced mitogenic signaling.
19. Muthalif MM, Benter IF, Karzoun N, Fatima S, Harper J, Uddin MR, Malik KU. 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci U S A. 1998;95:12701-12706.
20. Amaral SL, Maier KG, Schippers DN, Roman RJ, Greene AS. CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis. Am J Physiol Heart Circ Physiol. 2003;284: H1528-H1535.
21. +)ATPase. Nature. 1985;314:620-622.
22. Escalante B, Erlij D, Falck JR, McGiff JC. Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science. 1991;251:799-802.
23. +-ATPase. J Clin Invest. 1997;99:1224-1230.
24. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev. 2002;82:131-185.
25. Okita RT, Okita JR. Cytochrome P450 4A fatty acid omega hydroxylases. Curr Drug Metab. 2001;2:265-281.
26. Miano JM, Carlson MJ, Spencer JA, Misra RP. Serum response factor-dependent regulation of the smooth muscle calponin gene. J Biol Chem. 2000;275:9814-9822.
27. Quan S, Yang L, Abraham NG, Kappas A. Regulation of human heme oxygenase in endothelial cells by using sense and antisense retroviral constructs. Proc Natl Acad Sci USA. 2001;98:12203-12208.
28. Miyata N, Taniguchi K, Seki T, Ishimoto T, Sato-Watanabe M, Yasuda Y, Doi M, Kametani S, Tomishima Y, Ueki T, Sato M, Kameo K. HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme. Br J Pharmacol. 2001;133:325-329.
29. Lund DD, Faraci FM, Miller FJ Jr, Heistad DD. Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits. Circulation. 2000;101:1027-1033.
30. Mezentsev A, Seta F, Dunn MW, Ono N, Falck JR, Laniado-Schwartzman M. Eicosanoid regulation of vascular endothelial growth factor expression and angiogenesis in microvessel endothelial cells. J Biol Chem. 2002; 277:18670-18676.
31. Zhu WH, MacIntyre A, Nicosia RF. Regulation of angiogenesis by vascular endothelial growth factor and angiopoietin-1 in the rat aorta model: distinct temporal patterns of intracellular signaling correlate with induction of angiogenic sprouting. Am J Pathol. 2002;161:823-830.
32. Brodsky SV, Smith M, Kashgarian M, Goligorsky MS. A model for ex vivo renal angiogenesis. Nephron Exp Nephrol. 2003;93:e46-e52.
33. Rekhter MD, Simari RD, Work CW, Nabel GJ, Nabel EG, Gordon D. Gene transfer into normal and atherosclerotic human blood vessels. Circ Res. 1998;82:1243-1252.
34. Rome JJ, Shayani V, Flugelman MY, Newman KD, Farb A, Virmani R, Dichek DA. Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall: modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscler Thromb. 1994;14:148-161.
35. Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis. 2001;37:601-611.
36. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, Schreiner GF, Johnson RJ. Role of the microvascular-endothelium in progressive renal disease. J Am Soc Nephrol. 2002;13:806-816.
37. Omata K, Abraham NG, Escalante B, Schwartzman ML. Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats. Am J Physiol. 1992;262:F8-F16.
38. Kroetz DL, Huse LM, Thuresson A, Grillo MP. Developmentally regulated expression of the CYP4A genes in the spontaneously hypertensive rat kidney. Mol Pharmacol. 1997;52:362-372.